Your browser doesn't support javascript.
loading
Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma.
Mistry, Kavita; Zhao, Sophia; Strohbehn, Ian; Wang, Qiyu; Hanna, Paul; Strohbehn, Samuel; Katz-Agranov, Nurit; Sullivan, Ryan J; Sise, Meghan E.
Afiliação
  • Mistry K; Department of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Zhao S; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Strohbehn I; Analytica Now LLC, Brookline, MA, USA.
  • Wang Q; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
  • Hanna P; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
  • Strohbehn S; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
  • Katz-Agranov N; Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Sullivan RJ; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
  • Sise ME; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
Nephrol Dial Transplant ; 39(6): 1040-1043, 2024 May 31.
Article em En | MEDLINE | ID: mdl-38389257

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article